Florence Mishellany
- Cancer Research top 10%
- Breast Cancer Treatment Studies 10
- Endocrine and Autonomic Systems top 10%
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 4
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment 5
-
- Radiopharmaceutical Chemistry and Applications 7
-
- Breast Lesions and Carcinomas 9
-
- Sarcoma Diagnosis and Treatment 5
-
- Adipokines, Inflammation, and Metabolic Diseases 5
-
- Reproductive Biology and Fertility 4
Florence Mishellany
32 papers receiving 800 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 217
- Endocrine and Autonomic Systems 82
- Oncology 295
- Reproductive Medicine 74
- Radiology, Nuclear Medicine and Imaging 138
Countries citing papers authored by Florence Mishellany
This map shows the geographic impact of Florence Mishellany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Mishellany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Mishellany more than expected).
Fields of papers citing papers by Florence Mishellany
This network shows the impact of papers produced by Florence Mishellany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Mishellany. The network helps show where Florence Mishellany may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Florence Mishellany, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 32 | |
| 2 | 2019 | 28 | |
| 3 | 2015 | 16 | |
| 4 | 2013 | 14 | |
| 5 | 2013 | 23 | |
| 6 | Zinc-alpha2-glycoprotein: a new biomarker of breast cancer? | 2010 | 33 |
| 7 | Melanoma vectorized radiotherapy: preclinical evaluation of a new marker labelled by iodine 131 | 2010 | 1 |
| 8 | 2010 | 3 | |
| 9 | 2009 | 131 | |
| 10 | 2009 | 38 | |
| 11 | 2009 | 2 | |
| 12 | 2009 | 21 | |
| 13 | 2009 | 14 | |
| 14 | 2008 | 6 | |
| 15 | 2008 | 11 | |
| 16 | 2008 | 5 | |
| 17 | 2007 | 33 | |
| 18 | 2007 | 4 | |
| 19 | 2006 | 3 | |
| 20 | 2003 | 64 |
About Florence Mishellany
Florence Mishellany is a scholar working on Cancer Research, Reproductive Medicine, Pathology and Forensic Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 37 papers that have together received 811 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (9 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Ovarian cancer diagnosis and treatment (5 papers), Sarcoma Diagnosis and Treatment (5 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers), Reproductive Biology and Fertility (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Cancer Research (217 citations), Endocrine and Autonomic Systems (82 citations), Oncology (295 citations), Reproductive Medicine (74 citations) and Radiology, Nuclear Medicine and Imaging (138 citations). Florence Mishellany has collaborated with scholars based in France, Germany and Canada. Frequent co-authors include Frédérique Penault‐Llorca, Thierry Jardé, Florence Caldefie‐Chezet, M.-P. Vasson, Anne Cayre, Nicolas Gonçalves-Mendes, Christa Buechler, G. Le Bouëdec, Mireille Damez and Jacques Guillot. Their work appears in journals such as International Journal of Cancer, International Journal of Gynecological Cancer, Neoplasia, Proceedings of The Nutrition Society and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.